- Exchange: OTC US
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Snapshot for AtheroNova Inc (AHRO)
| Open: | 0.7500 | Day's Range: | 0.7300 - 0.7500 | Volume: | 8,400 |
|---|---|---|---|---|---|
| Previous Close: | 0.7300 | 52wk Range: | 0.3500 - 1.0700 | 1-Yr Rtn: | +13.88% |
Key Statistics for AHRO
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (USD) (ttm) | -0.1800 |
| Est. EPS (USD) (12/2013) | -0.0800 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 28.22 |
| Shares Outstanding (M) | 38.66 |
| 30 Day Average Volume | 17,368 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 05/24/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for AHRO
Company Profile & Key Executives for AHRO
AtheroNova, Inc. researches treatments for clogged arteries. The Company researches natural compounds to regress arterial atherosclerotic plaque deposits.
| Thomas W GardnerChairman/President/CEO | Mark SelawskiCFO/Secretary |
| Mark K WedelChief Medical Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
AHRO News
-
Industry News
No stories found
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page